Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Planning Grants - PA: Health Services and Systems for an Aging Population

University of British Columbia

$22,250.00

Planning the Examiniation of Serious Drug Adverse Events with Prescription Drugs used by Older Men

EF 2012-13

Résumé
Adverse drug events (ADEs) have shown to be a major contributor to morbidity and mortality in Canada. In the United States ADEs have shown to contribute to approximately 9 million hospitalization annually. In recent years, pharamcoepidemiologic studies that use health care administrative databases have provided valuable information on drug adverse events. Many of these studies have been published in the area of chronic diseases in older adults. In fact, numerous studies and initiatives have been focused on clinically important but drug ADEs that affect Women's Health. For example, The Women's Health Initiative was a large randomized controlled trial that addressed many health related issues including the effect of hormone replacement therapy and various forms of cancers in women. Unfortunately, similar initiatives that that focus on examining ADEs in older men are absent. This is in light of the fact that millions of prescriptions are written annually in Canada and United States for alpha blockers and 5-alpha-reductase inhibitors (5ARIs), one of the most prescribed classes of drugs used by older men. Both these drug classes have been linked to serious adverse events including cancer, liver injury and various ocular diseases through case reports submitted to the Food and Drug Administration and Health Canada. Currently, large epidemiologic studies that have examined these adverse events in a real clinical setting are absent. The primary objective of this grant is to bring together experts in the area of clinical pharmacology, pharmacoepidemiology, biostatatistics, knowledge translation, drug policy and urology. Specifically we plan to 1) discuss the creation of the first drug safety initiative in older men;2) discuss and outline specific methodological approaches for each study question;3) identify potential funding opportunities for each study question. We plan to submit at least one operating grant to CIHR in the Fall of 2013.
Programme
Planning Grants - PA: Health Services and Systems for an Aging Population
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
273126
Name
Etminan Mahyar
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Planning Grants
Projecttitle
Planning the Examiniation of Serious Drug Adverse Events with Prescription Drugs used by Older Men
Programtype2
Miscellaneous Programs
Orgnameinp2
University of British Columbia
Cihramount2
$22,250
Cihrequipment2
$0
Programname2
Planning Grants - PA: Health Services and Systems for an Aging Population
Keyworddelim
5-Alpha Reductase Inhibitors; Alpha Blockers; Case-Control Studies; Drug Adverse Events In Older Adults; Large Health Care Databases; Older Men; Pharmacoepidemiology; Prescription Drugs Used By Older Men; Self Controlled-Case Series
Abstract
Adverse drug events (ADEs) have shown to be a major contributor to morbidity and mortality in Canada. In the United States ADEs have shown to contribute to approximately 9 million hospitalization annually. In recent years, pharamcoepidemiologic studies that use health care administrative databases have provided valuable information on drug adverse events. Many of these studies have been published in the area of chronic diseases in older adults. In fact, numerous studies and initiatives have been focused on clinically important but drug ADEs that affect Women's Health. For example, The Women's Health Initiative was a large randomized controlled trial that addressed many health related issues including the effect of hormone replacement therapy and various forms of cancers in women. Unfortunately, similar initiatives that that focus on examining ADEs in older men are absent. This is in light of the fact that millions of prescriptions are written annually in Canada and United States for alpha blockers and 5-alpha-reductase inhibitors (5ARIs), one of the most prescribed classes of drugs used by older men. Both these drug classes have been linked to serious adverse events including cancer, liver injury and various ocular diseases through case reports submitted to the Food and Drug Administration and Health Canada. Currently, large epidemiologic studies that have examined these adverse events in a real clinical setting are absent. The primary objective of this grant is to bring together experts in the area of clinical pharmacology, pharmacoepidemiology, biostatatistics, knowledge translation, drug policy and urology. Specifically we plan to 1) discuss the creation of the first drug safety initiative in older men;2) discuss and outline specific methodological approaches for each study question;3) identify potential funding opportunities for each study question. We plan to submit at least one operating grant to CIHR in the Fall of 2013.
Competitiondate
201210
Approvedterm2
1 yr 0 mth
Pinamesdelim
Etminan, Mahyar
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $22,250~ $0~